NYBC Ventures

NYBC Ventures is at the forefront of advancing innovation within the medical and diagnostic laboratories sector, specifically focusing on blood-related and cellular medicines and technologies. As a dedicated venture fund, NYBC Ventures employs a model of patient capital, taking an agnostic approach to financing vehicles and structures. This strategic approach allows NYBC Ventures to evaluate investment and collaborative opportunities across various critical areas, including benign hematology, infectious diseases, transfusion medicine, cell therapy, and regenerative medicine.

NYBC Ventures has developed streamlined scientific and investment due diligence teams to ensure thorough and effective evaluation processes. The company is committed to driving progress and making significant contributions to the medical field through strategic investments and collaborations. NYBC Ventures strives to support groundbreaking advancements that improve patient outcomes and transform healthcare.

NYBC Ventures continues to expand its reach and impact within the industry, fostering innovation and collaboration to address some of the most pressing medical challenges. We invite the management team at NYBC Ventures to take advantage of our platform to create a customized and exclusive company showcase and product listing, enhancing their visibility and fostering new opportunities.